Asset sale Announced
Apotex acquisition of Cumberland U.S. branded businesses
Announced Apr 2026
Advisers
Cumberland U.S. branded businesses
Target
Not disclosed
Apotex
Acquirer
- Legal adviser
- Target
- Cumberland U.S. branded businesses
- Acquirer
- Apotex
- Seller
- Cumberland Pharmaceuticals
- Target based in
- United States
- Buyer based in
- Canada
- Seller based in
- United States
- Sector
- Pharma
In the league tables
Similar deals
- Fresenius acquisition of mAbxience Oct 2026 · US$1.9bn · Biotech
- Gilead acquisition of HCXT-2001 (investigational oral IL-23R inhibitor) Oct 2026 · Pharma
- US WorldMeds acquisition of Orbus Therapeutics Oct 2026 · Pharma
- DRI Healthcare Trust acquisition of Royalty participation rights in U.S. net sales of tavapadon Sep 2026 · US$316m · Specialty finance and leasing
- Grünenthal acquisition of Stivarga (regorafenib) Sep 2026 · US$433m · Pharma
